Phase II study on feasibility of sentinel lymph node biopsy for ycN0 patients treated with primary chemotherapy in cT1-3N1M0 breast cancer
Not Applicable
Recruiting
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000030558
- Lead Sponsor
- Japanese Society for Sentinel Node Navigation Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 240
Inclusion Criteria
Not provided
Exclusion Criteria
1) Non-invasive cancer, or T4 and/or M1 breast cancer. 2) Clinical N0 or N2 and more metastases. 3) Women with pregnancy or breast-feeding. 4) Synchronous bilateral breast cancer 5) Cases with other invasive disease during treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method false negative rate of sentinel node biopsy
- Secondary Outcome Measures
Name Time Method